Loading
Latest filing published 14 Mar 2017 for Kane Biotech Inc.. Read the official filing
Mark Henry Nawacki discloses dealings in Kane Biotech Inc. to SEDI. Between 8 October 2014 and 10 March 2017, the trades on record add up to 7 filings.
No open-market sale appears; the market trades are 1 purchase worth €3,342. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 2 option exercises.
On 14 March 2017 came the latest disclosure, a transaction in Kane Biotech Inc. The last insider purchase was made public on 8 May 2016, 3,818 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 5 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations